SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038008
Filing Date
2023-11-09
Accepted
2023-11-09 06:05:11
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocgn-20230930.htm   iXBRL 10-Q 953739
2 EX-31.1 ocgn-20230930x10qxex311.htm EX-31.1 10006
3 EX-31.2 ocgn-20230930x10qxex312.htm EX-31.2 10048
4 EX-32.1 ocgn-20230930x10qxex321.htm EX-32.1 7358
10 GRAPHIC ocgn-20230930_g1.jpg GRAPHIC 27940
  Complete submission text file 0001628280-23-038008.txt   5075082

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20230930.xsd EX-101.SCH 34350
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocgn-20230930_cal.xml EX-101.CAL 56956
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocgn-20230930_def.xml EX-101.DEF 161878
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20230930_lab.xml EX-101.LAB 470695
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20230930_pre.xml EX-101.PRE 297037
59 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20230930_htm.xml XML 570965
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36751 | Film No.: 231389848
SIC: 2836 Biological Products, (No Diagnostic Substances)